Hyperopia - It's certainly a heard mentality by BP's to have FOMO over the latest modalities, despite being way early, with absolutely no data as yet in regards to "safety and effectiveness." They consider ownership on the cheap to keep their options open to be worth the investment. While in the meantime, we're seeing catastrophic reports of malignancies caused by a long least of Gene Therapies based on genetically modified autologous lysates using viral vectors, which have been known to be an open invitation to unintended mutagenesis leading to malignancy.
News 
Market Data 
Discover 
